Precision Molecular Pathology of Glioblastoma (Paperback) (ISBN-13: 9783030691721)

José Javier Otero, M.D., Ph.D. Director of NeuropathologyThe Ohio State University College of MedicineDepartment of Pathology333 West 10th Ave.Columbus, OH 43210
Dr. Otero is the Director of Neuropathology at The Ohio State University College of Medicine. Neuropathology at Ohio State is responsible for all Surgical Neuropathology and Autopsy Diagnostics for James Cancer Center and Wexner Medical Center, in addition to reviewing consults from community pathologists throughout the United States. Dr. Otero obtained his M.D., Ph.D. degree from Northwestern University (Chicago, IL) where he was mentored by Dr. John Kessler during his graduate dissertation. He then transitioned to University of California, San Francisco for anatomic pathology and neuropathology residency, followed by a post-doctoral fellowship in the laboratory of Dr. David Rowitch. Dr. Otero is an expert in developmental neurobiologyand surgical neuropathology.

Aline Becker, M.D., Ph.D.The Ohio State University Comprehensive Cancer Center - James Cancer HospitalDepartment of Radiation Oncology400 W 12th AvenueColumbus, OH 43210E-Mail: aline.becker@osumc.edu

Dr. Becker is a physician-scientist formally trained as anatomic pathologist in her home country of Brazil, with large experience in Neuropathology and Molecular Pathology of adult and pediatric brain tumors. She obtained her Neuropathology training at the University of Sao Paulo, campus Ribeirao Preto, a world-renowned institution and one of the premier academic centers for Neuro-Oncology in Brazil. Her Doctoral degree in Molecular Pathology was obtained under the mentorship from Dr. Rui Manuel Reis. She is currently the Research Neuropathologist (Senior Research Associate) in the Chakravarti laboratory at The Ohio State University, where she has worked inthe discovery and validation of molecular biomarkers, development of new treatments with small molecule inhibitors and FLASH radiation, and elucidation of treatment resistance mechanisms in glioblastoma.